<code id='E6D5CCD9D9'></code><style id='E6D5CCD9D9'></style>
    • <acronym id='E6D5CCD9D9'></acronym>
      <center id='E6D5CCD9D9'><center id='E6D5CCD9D9'><tfoot id='E6D5CCD9D9'></tfoot></center><abbr id='E6D5CCD9D9'><dir id='E6D5CCD9D9'><tfoot id='E6D5CCD9D9'></tfoot><noframes id='E6D5CCD9D9'>

    • <optgroup id='E6D5CCD9D9'><strike id='E6D5CCD9D9'><sup id='E6D5CCD9D9'></sup></strike><code id='E6D5CCD9D9'></code></optgroup>
        1. <b id='E6D5CCD9D9'><label id='E6D5CCD9D9'><select id='E6D5CCD9D9'><dt id='E6D5CCD9D9'><span id='E6D5CCD9D9'></span></dt></select></label></b><u id='E6D5CCD9D9'></u>
          <i id='E6D5CCD9D9'><strike id='E6D5CCD9D9'><tt id='E6D5CCD9D9'><pre id='E6D5CCD9D9'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:95
          Alastair Grant/AP

          LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

          The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

          advertisement

          AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          How to increase colonoscopy rates? Looks like an AI can help
          How to increase colonoscopy rates? Looks like an AI can help

          AdobeCHICAGO—Peoplecanbemightilyreluctanttogetacolonoscopyforreasonslikecost,languagebarriers,orfear

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          FDA gives detailed accounting of AI

          AdobeTheFoodandDrugAdministrationonThursdayreleasedanewaccountingofartificialintelligencetoolscleare